In a World of Medicines Without Myths: Why Generic Medicines from Darnytsia Are a Smart Choice for Health
Generic medicines have become an integral part of modern medical practice, providing millions of patients with access to high-quality and effective treatment.
Despite the widespread use of generics, there are still many misconceptions surrounding them that influence both consumer choices and the professional activities of healthcare providers.
Darnytsia Pharmaceutical Company highlights the key advantages of modern generics, dispels common myths, and emphasizes the importance of trusting evidence-based medical decisions.
Myth 1. Generics are inferior to original medicines in quality and efficacy
Fact: Every generic medicine contains the identical active substance and has proven bioequivalence to the original. Independent clinical studies and strict registration procedures guarantee the effectiveness and safety of generics at the same level as original drugs.
In particular, Darnytsia implements the same standards as global pharmaceutical companies, enabling the creation of medicines trusted not only in Ukraine but also across Europe.
Myth 2. Quality control of generics is insufficient
Fact: Production of generic medicines is carried out according to international GMP standards, and every batch undergoes multi-stage testing and route audits. Constant supervision from regulatory authorities ensures reliability and safety for consumers.
Moreover, Darnytsia’s production facilities are equipped with the latest equipment from leading suppliers — Glatt, Korsh, Schafer, Wipotec-OCS (Germany), Fette (France), Marchesini Group, IMA Group (Italy), Steris (Ireland). The same equipment is used by pharmaceutical giants such as Pfizer, Eli Lilly, Novartis, Sanofi, and GlaxoSmithKline.
Myth 3. Generics are produced from low-quality or cheap raw materials
Fact: Modern pharmaceutical companies, including Darnytsia, use components only from certified and verified suppliers. All manufacturing processes comply with strict regulatory requirements, ensuring the quality of every batch of finished products.
For example, 60% of the raw materials used by Darnytsia are produced in Europe, and 40% in the Asia-Pacific region. All raw materials meet the requirements of the European Pharmacopoeia (EP), United States Pharmacopeia (USP), and British Pharmacopoeia (BP).
Medicines from Darnytsia are used daily in leading healthcare institutions of the country, and their effectiveness is confirmed both in laboratories and by patients and medical experts.
Generics from Darnytsia help take care of the health of the whole family without overpaying for a brand name or fancy packaging.
Don’t let myths influence your treatment decisions. Choose generics from Darnytsia — modern, safe, and proven remedies trusted by millions.